18:0 DAP

CAT: 0804-HY-143700-01Size: 25 mgDry Ice: NoHazardous: No
CAT#:0804-HY-143700-01Size:25 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
18:0 DAP can be used to formulate lipid nanoparticles (LNPs), which mRNA is encapsulated in their core[1].
CAS Number
[121315-93-3]
UNSPSC
12352200
Hazard Statement
H302, H315, H319, H331, H336, H351, H361, H372
Target
Liposome
Type
Biochemical Assay Reagents
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/18-0-dap.html
Purity
99.99
Solubility
10 mM in DMSO
Smiles
CN(CC(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O)C
Molecular Formula
C41H81NO4
Molecular Weight
652.09
Precautions
H302, H315, H319, H331, H336, H351, H361, H372
References & Citations
[1]Patel S, et al. Lipid nanoparticles for delivery of messenger RNA to the back of the eye. J Control Release. 2019;303:91-100.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported

Related Products

CatalogName
HY-144020-0114:0 DAP
HY-144022-0116:0 DAP
HY-146893S-0118:0-18:0 PC-d35
HY-N11142Gb3 (18:1/18:0)
HY-143203-0118:0-18:2 PE
HY-N1631718:0 mPEG2000
HY-17117018:0-LPS
HY-N1578218:0-PhoDAG
HY-16020318:0 Cardiolipin
HY-154918-01LysoPE (18:2/0:0)

Alternative Products

CatalogName
MF-0054623-0118:0-18:2 PE
MF-0054614-0118:0 mPEG2000
MF-0054632-0118:0-PhoDAG
BIPG2299-0118:0 TAP
MF-0054631-0118:0-LPS
MF-0054603-0118:0 DAP
MF-0054624-0118:0-18:2 PG sodium
MF-0054622-0118:0-18:1 PA sodium
MF-0054619-0118:0,18:1 PS sodium
M34930-01PE (18:1 (9Z) /0:0)

Popular Products